Status:
COMPLETED
Misoprostol Administration Before Operative Hysteroscopy
Lead Sponsor:
CHA University
Conditions:
Endometrial Disorder
Eligibility:
FEMALE
18-55 years
Phase:
PHASE3
Brief Summary
The objective of this study is to compare the efficacy of oral, sublingual, vaginal, and no misoprostol prior to operative hysteroscopy in premenopausal women.
Detailed Description
The route of administration of misoprostol for cervical dilatation prior to operative hysteroscopy can be oral, vaginal, or sublingual. However, it is still unclear which route is more effective and l...
Eligibility Criteria
Inclusion
- Symptomatic patients that were suspected as having intrauterine pathology, such as submucosal myoma, endometrial polyp or other endometrial pathological findings based on the transvaginal ultrasound, were enrolled.
- Inclusion criteria were as follows: women who were of reproductive age (i.e., were premenopausal) and were not pregnant at the time of presentation (i.e., negative for urine pregnancy test or last menstrual period within the last 4 weeks). -
Exclusion
- Exclusion criteria included any evidence of a contraindication to prostaglandins (history of severe asthma, glaucoma, preexisting severe cardiac disease, or renal failure), or allergy to prostaglandins, any sign of genital infection, presence of significant uterovaginal prolapse that could affect administration of vaginal tablets, history of cervical surgery, presence of space occupying lesions in endocervical canal, and treatment of GnRH agonist.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01805115
Start Date
March 1 2013
End Date
February 1 2014
Last Update
December 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHA Gangnam Medical Center
Seoul, South Korea, 135-081